Expert Perspective
CGRPs: They’ve Been a Long Time Coming
Clinical Edge Journal Scan
Clinical Edge Journal Scan Commentary: Migraine May 2022
Clinical Edge Journal Scan
Meta-analysis backs the clinically significant effects of transcutaneous nerve stimulation in migraine
Clinical Edge Journal Scan
Fremanezumab effective and safe for high-frequency episodic and chronic migraine in real world
Clinical Edge Journal Scan
CGRP mAb vs. standard treatments offer better adherence and persistence in migraine
Clinical Edge Journal Scan
Ultrasound-guided stellate ganglion block: An effective treatment strategy for migraine
Clinical Edge Journal Scan
Effect of CGRP-receptor mAb therapy resumption after a drug holiday on migraine frequency
Clinical Edge Journal Scan
Chronic migraine: Topiramate performs better when combined with greater occipital nerve block
Clinical Edge Journal Scan
External trigeminal nerve stimulation: A nonpharmacological alternative for the acute treatment of migraine attacks
Clinical Edge Journal Scan
Fremanezumab effective in difficult-to-treat migraine with associated neurological dysfunction
Clinical Edge Journal Scan
Eptinezumab can prevent self-reported migraine with aura
Clinical Edge Journal Scan
Galcanezumab shows long-term efficacy and safety in chronic migraine
Conference Coverage
Migraine linked to preeclampsia and other pregnancy complications
Women with a history of migraine may benefit from enhanced monitoring during pregnancy.
Clinical Edge Journal Scan
Clinical Edge Journal Scan Commentary: Migraine April 2022
Literature Review
Targeting the endocannabinoid system in migraine
Cannabis and other compounds that interact with the endocannabinoid system may be able to modulate the pathways involved in migraine-related pain...